Literature DB >> 21136152

Selective extraction and effective separation of galactosylsphingosine (psychosine) and glucosylsphingosine from other glycosphingolipids in pathological tissue samples.

Yu-Teh Li1, Su-Chen Li, Wayne R Buck, Mark E Haskins, Sz-Wei Wu, Kay-Hooi Khoo, Ellen Sidransky, Bruce A Bunnell.   

Abstract

To facilitate the study of the chemical pathology of galactosylsphingosine (psychosine, GalSph) in Krabbe disease and glucosylsphingosine (GlcSph) in Gaucher disease, we have devised a facile method for the effective separation of these two glycosylsphingosines from other glycosphingolipids (GSLs) in Krabbe brain and Gaucher spleen samples. The procedure involves the use of acetone to selectively extract GalSph and GlcSph, respectively, from Krabbe brain and Gaucher spleen samples. Since acetone does not extract other GSLs except modest amounts of galactosylceramide, sulfatide, and glucosylceramide, the positively charged GalSph or GlcSph in the acetone extract can be readily separated from other GSLs by batchwise cation-exchange chromatography using a Waters Accell Plus CM Cartridge. GalSph or GlcSph enriched by this simple procedure can be readily analyzed by thin-layer chromatography or high-performance liquid chromatography.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21136152      PMCID: PMC3340580          DOI: 10.1007/s11064-010-0348-3

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  16 in total

1.  Diphenylamine-aniline-phosphoric acid reagent, a versatile spray reagent for revealing glycoconjugates on thin-layer chromatography plates.

Authors:  K Anderson; S C Li; Y T Li
Journal:  Anal Biochem       Date:  2000-12-15       Impact factor: 3.365

2.  On the preparation of cholesterin from brain.

Authors:  O Rosenheim
Journal:  J Physiol       Date:  1906-03-13       Impact factor: 5.182

Review 3.  Glucocerebrosidase gene mutations in patients with type 2 Gaucher disease.

Authors:  D L Stone; N Tayebi; E Orvisky; B Stubblefield; V Madike; E Sidransky
Journal:  Hum Mutat       Date:  2000       Impact factor: 4.878

4.  Genetic galactocerebrosidase deficiency (globoid cell leukodystrophy, Krabbe disease) in rhesus monkeys (Macaca mulatta).

Authors:  G B Baskin; M Ratterree; B B Davison; K P Falkenstein; M R Clarke; J D England; M T Vanier; P Luzi; M A Rafi; D A Wenger
Journal:  Lab Anim Sci       Date:  1998-10

5.  Quantification of galactosylsphingosine in the twitcher mouse using electrospray ionization-tandem mass spectrometry.

Authors:  P D Whitfield; P C Sharp; R Taylor; P Meikle
Journal:  J Lipid Res       Date:  2001-12       Impact factor: 5.922

6.  Novel procedure for measuring psychosine derivatives by an HPLC method.

Authors:  M Nozawa; T Iwamoto; T Tokoro; Y Eto
Journal:  J Neurochem       Date:  1992-08       Impact factor: 5.372

7.  Krabbe disease: a galactosylsphingosine (psychosine) lipidosis.

Authors:  L Svennerholm; M T Vanier; J E Månsson
Journal:  J Lipid Res       Date:  1980-01       Impact factor: 5.922

8.  Quantitation of free sphingosine in liver by high-performance liquid chromatography.

Authors:  A H Merrill; E Wang; R E Mullins; W C Jamison; S Nimkar; D C Liotta
Journal:  Anal Biochem       Date:  1988-06       Impact factor: 3.365

9.  The occurrence of psychosine and other glycolipids in spleen and liver from the three major types of Gaucher's disease.

Authors:  O Nilsson; J E Månsson; G Håkansson; L Svennerholm
Journal:  Biochim Biophys Acta       Date:  1982-09-14

10.  Analysis of galactosylsphingosine (psychosine) in the brain.

Authors:  H Igisu; K Suzuki
Journal:  J Lipid Res       Date:  1984-09       Impact factor: 5.922

View more
  5 in total

1.  Multiplex analysis of sphingolipids using amine-reactive tags (iTRAQ).

Authors:  Takuji Nabetani; Asami Makino; Françoise Hullin-Matsuda; Taka-Aki Hirakawa; Shinji Takeoka; Nozomu Okino; Makoto Ito; Toshihide Kobayashi; Yoshio Hirabayashi
Journal:  J Lipid Res       Date:  2011-04-12       Impact factor: 5.922

2.  A HILIC-MS/MS method for simultaneous quantification of the lysosomal disease markers galactosylsphingosine and glucosylsphingosine in mouse serum.

Authors:  Rohini Sidhu; Christina R Mikulka; Hideji Fujiwara; Mark S Sands; Jean E Schaffer; Daniel S Ory; Xuntian Jiang
Journal:  Biomed Chromatogr       Date:  2018-04-26       Impact factor: 1.902

3.  Characterization and application of a disease-cell model for a neurodegenerative lysosomal disease.

Authors:  Jameson J Ribbens; Ann B Moser; Walter C Hubbard; Ernesto R Bongarzone; Gustavo H B Maegawa
Journal:  Mol Genet Metab       Date:  2013-09-21       Impact factor: 4.797

4.  Inhibition of angiogenesis by β-galactosylceramidase deficiency in globoid cell leukodystrophy.

Authors:  Mirella Belleri; Roberto Ronca; Daniela Coltrini; Beatrice Nico; Domenico Ribatti; Pietro L Poliani; Arianna Giacomini; Patrizia Alessi; Sergio Marchesini; Marta B Santos; Ernesto R Bongarzone; Marco Presta
Journal:  Brain       Date:  2013-09       Impact factor: 13.501

5.  β-Galactosylceramidase Deficiency Causes Upregulation of Long Pentraxin-3 in the Central Nervous System of Krabbe Patients and Twitcher Mice.

Authors:  Daniela Coltrini; Adwaid Manu Krishna Chandran; Mirella Belleri; Pietro L Poliani; Manuela Cominelli; Francesca Pagani; Miriam Capra; Stefano Calza; Simona Prioni; Laura Mauri; Alessandro Prinetti; Julia K Kofler; Maria L Escolar; Marco Presta
Journal:  Int J Mol Sci       Date:  2022-08-21       Impact factor: 6.208

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.